Multiorgan Manifestation

PTH Deficiency—Systemic Impact That Puts Multiple
Organs at Risk1-3

A range of symptoms and risks are associated with PTH deficiency and conventional therapy1-3

CENTRAL NERVOUS SYSTEM
  • Seizures
  • Basal ganglia calcifications
  • Parkinsonism or dystonia
CARDIOVASCULAR SYSTEM
  • Cardiac arrhythmias
  • Hypocalcemia-associated dilated cardiomyopathy
  • Vascular calcifications
RENAL SYSTEM
  • Chronic kidney disease*
  • Nephrocalcinosis*
  • Nephrolithiasis*
NEUROMUSCULAR SYSTEM
  • Myopathy
  • Muscle cramps/tetany
  • Paresthesia
NEUROPSYCHIATRIC SYSTEM
  • Cognitive impairment ("brain fog")
  • Symptoms of anxiety and depression
MUSCULOSKELETAL SYSTEM
  • Reduced bone turnover
  • Increased bone density
  • Spondyloarthropathy
CENTRAL NERVOUS SYSTEM
  • Seizures
  • Basal ganglia calcifications
  • Parkinsonism or dystonia
CARDIOVASCULAR SYSTEM
  • Cardiac arrhythmias
  • Hypocalcemia-associated dilated cardiomyopathy
  • Vascular calcifications
NEUROMUSCULAR SYSTEM
  • Myopathy
  • Muscle cramps/tetany
  • Paresthesia
NEUROPSYCHIATRIC SYSTEM
  • Cognitive impairment ("brain fog")
  • Symptoms of anxiety and depression
RENAL SYSTEM
  • Chronic kidney disease*
  • Nephrocalcinosis*
  • Nephrolithiasis*
MUSCULOSKELETAL SYSTEM
  • Reduced bone turnover
  • Increased bone density
  • Spondyloarthropathy
  Adapted by permission from Springer Nature. Nature Reviews Disease Primers. 2017;3:17055. Hypoparathyroidism. Mannstadt M, et al. 2017.
* These manifestations are mostly the result of treatment with pharmacologically high doses of calcium and calcitriol (active vitamin D) rather than of the disease itself.3
Watch Mechanism of Disease video

Look deeper at the impact of PTH deficiency on
specific organ systems.